Mead Johnson Nutrition CO (MJN) : Fieldpoint Private Advisors Inc reduced its stake in Mead Johnson Nutrition CO by 1.38% during the most recent quarter end. The investment management company now holds a total of 39,350 shares of Mead Johnson Nutrition CO which is valued at $3.3 Million after selling 550 shares in Mead Johnson Nutrition CO , the firm said in a disclosure report filed with the SEC on May 11, 2016.Mead Johnson Nutrition CO makes up approximately 2.38% of Fieldpoint Private Advisors Inc’s portfolio.
Other Hedge Funds, Including , Zevenbergen Capital Investments boosted its stake in MJN in the latest quarter, The investment management firm added 1,450 additional shares and now holds a total of 5,620 shares of Mead Johnson Nutrition CO which is valued at $470,450. Mead Johnson Nutrition CO makes up approx 0.02% of Zevenbergen Capital Investments’s portfolio. Ft Options added MJN to its portfolio by purchasing 1,100 company shares during the most recent quarter which is valued at $92,081. Mead Johnson Nutrition CO makes up approx 0.16% of Ft Options’s portfolio.Dubuque Bank Trust Co reduced its stake in MJN by selling 26 shares or 66.67% in the most recent quarter. The Hedge Fund company now holds 13 shares of MJN which is valued at $1,106. Pacad Investment Ltd. added MJN to its portfolio by purchasing 12,200 company shares during the most recent quarter which is valued at $1 Million. Mead Johnson Nutrition CO makes up approx 0.12% of Pacad Investment Ltd.’s portfolio.Geneva Advisors reduced its stake in MJN by selling 4,830 shares or 15.42% in the most recent quarter. The Hedge Fund company now holds 26,500 shares of MJN which is valued at $2.3 Million. Mead Johnson Nutrition CO makes up approx 0.05% of Geneva Advisors’s portfolio.
Mead Johnson Nutrition CO opened for trading at $83.68 and hit $85.08 on the upside on Monday, eventually ending the session at $84.85, with a gain of 1.36% or 1.14 points. The heightened volatility saw the trading volume jump to 8,34,964 shares. Company has a market cap of $15,838 M.
On the company’s financial health, Mead Johnson Nutrition CO reported $0.87 EPS for the quarter, beating the analyst consensus estimate by $ 0.03 according to the earnings call on Apr 28, 2016. Analyst had a consensus of $0.84. The company had revenue of $962.10 million for the quarter, compared to analysts expectations of $954.99 million. The company’s revenue was down -12.1 % compared to the same quarter last year.During the same quarter in the previous year, the company posted $1.09 EPS.
Many Wall Street Analysts have commented on Mead Johnson Nutrition CO. Mead Johnson Nutrition CO was Upgraded by Credit Suisse to ” Outperform” on Mar 16, 2016.
Mead Johnson Nutrition Company (Mead Johnson) is a global pediatric nutrition company. The Company manufactures distributes and sells infant formulas children’s nutrition and other nutritional products. Its product portfolio includes routine and specialty infant formulas childrens milks and milk modifiers dietary supplements for pregnant and breastfeeding mothers pediatric vitamins and products for pediatric metabolic disorders. The Company operates through three segments: Asia Latin America and North America/Europe. The Company’s Enfa family of brands including Enfamil infant formula is a brand franchise in pediatric nutrition. Its product portfolio addresses a range of nutritional needs for infants children and expectant and nursing mothers. The Company markets its portfolio of more than 70 products to mothers healthcare professionals and retailers in more than 50 countries in Asia North America Latin America and Europe.